miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer
Authors
Keywords
miR-124, non-small cell lung cancer, gefitinib-resistance, SNAI2, STAT3
Journal
Journal of Huazhong University of Science and Technology-Medical Sciences
Volume 36, Issue 6, Pages 839-845
Publisher
Springer Nature
Online
2018-01-09
DOI
10.1007/s11596-016-1672-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis
- (2016) Lidong Zu et al. CARCINOGENESIS
- miR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma
- (2016) XIAOYING WANG et al. ONCOLOGY REPORTS
- Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
- (2016) Peixin Dong et al. Oncotarget
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma
- (2015) M. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
- (2015) M Saitoh et al. ONCOGENE
- NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10
- (2015) Yingjia Sun et al. Oncotarget
- Mechanisms of resistance to EGFR tyrosine kinase inhibitors
- (2015) Lihua Huang et al. Acta Pharmaceutica Sinica B
- Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
- (2015) Kai Wu et al. Oncotarget
- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The TGF -miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
- (2014) E. Izumchenko et al. CANCER RESEARCH
- The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients
- (2014) XIUMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Preclinical Rationale for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal Growth Factor Receptor Inhibitor-Resistant Non–Small-Cell Lung Cancer
- (2013) Shirish M. Gadgeel et al. Clinical Lung Cancer
- Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
- (2013) Samy Lamouille et al. CURRENT OPINION IN CELL BIOLOGY
- MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
- (2013) K. Kitamura et al. MOLECULAR CANCER THERAPEUTICS
- JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation
- (2012) Daijiro Harada et al. CANCER SCIENCE
- MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
- (2012) Yong-Jun Liang et al. CARCINOGENESIS
- Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
- (2012) Tudor Ciuleanu et al. LANCET ONCOLOGY
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
- (2012) Fariz Nurwidya et al. Cancer Research and Treatment
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
- (2011) Hua Xiong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
- (2010) Federico Cappuzzo et al. LANCET ONCOLOGY
- Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators
- (2008) H.-W. Lo et al. CLINICAL CANCER RESEARCH
- DNA methylomes, histone codes and miRNAs: Tying it all together
- (2008) Sònia Guil et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started